The Prevalence, Impact and Economic Implications of Atrial Fibrillation in Stroke: What Progress Has Been Made?
暂无分享,去创建一个
[1] S. Pocock,et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2007, Preventive medicine.
[2] R B D'Agostino,et al. Stroke severity in atrial fibrillation. The Framingham Study. , 1996, Stroke.
[3] P. Macfarlane,et al. The Routine Electrocardiogram for Cardiovascular Risk Stratification in Old Age: The Leiden 85‐Plus Study , 2007, Journal of the American Geriatrics Society.
[4] B. Gage,et al. Cost-Effectiveness of Dabigatran for Stroke Prophylaxis in Atrial Fibrillation , 2010, Circulation.
[5] Emma Heeley,et al. Chronic atrial fibrillation: Incidence, prevalence, and prediction of stroke using the Congestive heart failure, Hypertension, Age >75, Diabetes mellitus, and prior Stroke or transient ischemic attack (CHADS2) risk stratification scheme. , 2008, American heart journal.
[6] S. Connolly,et al. Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: A Canadian payer perspective , 2011, Thrombosis and Haemostasis.
[7] T. Dawber,et al. The Framingham Study , 2014 .
[8] J. Gardin,et al. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). , 1994, The American journal of cardiology.
[9] A. Go,et al. Racial variation in the prevalence of atrial fibrillation among patients with heart failure: the Epidemiology, Practice, Outcomes, and Costs of Heart Failure (EPOCH) study. , 2004, Journal of the American College of Cardiology.
[10] C. Sudlow,et al. Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. International Stroke Incidence Collaboration. , 1997, Stroke.
[11] K. Chien,et al. Atrial fibrillation prevalence, incidence and risk of stroke and all-cause death among Chinese. , 2010, International journal of cardiology.
[12] J. Cox,et al. The impact of warfarin use on clinical outcomes in atrial fibrillation: a population-based study. , 2007, The Canadian journal of cardiology.
[13] A. John Camm,et al. Clinical Relevance of Silent Atrial Fibrillation: Prevalence, Prognosis, Quality of Life, and Management , 2000, Journal of Interventional Cardiac Electrophysiology.
[14] Pierre Côté,et al. Loss to Follow-Up in Cohort Studies: How Much is Too Much? , 2003, European Journal of Epidemiology.
[15] E. Glader,et al. The effect of atrial fibrillation on stroke-related inpatient costs in Sweden: a 3-year analysis of registry incidence data from 2001. , 2008, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[16] P A Wolf,et al. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. , 1998, The American journal of cardiology.
[17] A. Waldo,et al. Chronic atrial fibrillation: Incidence, prevalence, and prediction of stroke using the Congestive heart failure, Hypertension, Age >75, Diabetes mellitus, and prior Stroke or transient ischemic attack (CHADS2) risk stratification scheme , 2009 .
[18] S. Pocock,et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, The Lancet.
[19] P. Barber,et al. Pathophysiological Determinants of Worse Stroke Outcome in Atrial Fibrillation , 2010, Cerebrovascular Diseases.
[20] T. Ng,et al. Low prevalence of atrial fibrillation in community-dwelling Chinese aged 55 years or older in Singapore: a population-based study. , 2008, Journal of electrocardiology.
[21] S. Willich,et al. Anticoagulation treatment for the reduction of stroke in atrial fibrillation: a cohort study to examine the gap between guidelines and routine medical practice , 2007, Journal of Thrombosis and Thrombolysis.
[22] Wei Chen,et al. HOW FAST IS THE POPULATION AGEING IN CHINA? , 2013 .
[23] R. P. Zhu,et al. Cost-Effectiveness of Dabigatran Compared With Warfarin for Stroke Prevention in Atrial Fibrillation , 2011, Annals of Internal Medicine.
[24] L. Parnetti,et al. Atrial fibrillation in patients with first‐ever stroke: frequency, antithrombotic treatment before the event and effect on clinical outcome , 2005, Journal of thrombosis and haemostasis : JTH.
[25] Robert Safford,et al. Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. , 2005, American heart journal.
[26] D. Cook,et al. Trends in the prevalence of diagnosed atrial fibrillation, its treatment with anticoagulation and predictors of such treatment in UK primary care , 2005, Heart.
[27] Theodor Landis,et al. Usefulness of Ambulatory 7-Day ECG Monitoring for the Detection of Atrial Fibrillation and Flutter After Acute Stroke and Transient Ischemic Attack , 2004, Stroke.
[28] C. Wolfe,et al. Characteristics, Outcome, and Care of Stroke Associated With Atrial Fibrillation in Europe: Data From a Multicenter Multinational Hospital–Based Registry (The European Community Stroke Project) , 2001, Stroke.
[29] D. Levy,et al. Prevention of Atrial Fibrillation: Report From a National Heart, Lung, and Blood Institute Workshop , 2009, Circulation.
[30] M. Kaste,et al. Direct Costs of Patients With Stroke Can Be Continuously Monitored on a National Level: Performance, Effectiveness, and Costs of Treatment Episodes in Stroke (PERFECT Stroke) Database in Finland , 2011, Stroke.
[31] S. Pocock,et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration , 2007, PLoS medicine.
[32] Luis Alberto García Rodríguez,et al. Risk of Cerebrovascular Accident After a First Diagnosis of Atrial Fibrillation , 2007, Clinical cardiology.
[33] G. Jensen,et al. Sex-specific increase in the prevalence of atrial fibrillation (The Copenhagen City Heart Study). , 2003, The American journal of cardiology.
[34] P. Wolf,et al. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. , 1991, Stroke.
[35] M. Costanza,et al. Low prevalence of atrial fibrillation in asymptomatic adults in Geneva, Switzerland. , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[36] W. Baker,et al. Meta-Analysis to Assess the Quality of Warfarin Control in Atrial Fibrillation Patients in the United States , 2009, Journal of managed care pharmacy : JMCP.
[37] P. Vestergaard,et al. Trends in incidence and mortality in the hospital diagnosis of atrial fibrillation or flutter in Denmark, 1980-1999. , 2005, International journal of cardiology.
[38] Simon Finfer,et al. SAFE (The Saline versus Albumin Fluid Evaluation) 試験 , 2006 .
[39] A. Camm,et al. The rhythm of the heart in active elderly subjects. , 1980, American heart journal.
[40] Simon Stewart,et al. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. , 2002, The American journal of medicine.
[41] E. Benjamin,et al. Status of the epidemiology of atrial fibrillation. , 2008, The Medical clinics of North America.
[42] A. Arboix,et al. Atrial fibrillation and stroke: clinical presentation of cardioembolic versus atherothrombotic infarction. , 2000, International journal of cardiology.
[43] G. Lip,et al. Atrial fibrillation and stroke prevention , 2007, The Lancet Neurology.
[44] D L Rosman,et al. Atrial fibrillation and mortality in an elderly population. , 1989, Australian and New Zealand journal of medicine.
[45] H. Uphoff,et al. Heterogeneous case definitions used for the surveillance of influenza in Europe , 2002, European Journal of Epidemiology.
[46] C. Yeh,et al. Underuse of Antithrombotic Therapy Caused High Incidence of Ischemic Stroke in Patients with Atrial Fibrillation , 2012, International journal of stroke : official journal of the International Stroke Society.
[47] C Fraser,et al. Laparoscopic surgery for inguinal hernia repair: systematic review of effectiveness and economic evaluation. , 2005, Health technology assessment.
[48] T. Truelsen,et al. Comparison of the impact of atrial fibrillation on the risk of stroke and cardiovascular death in women versus men (The Copenhagen City Heart Study). , 2004, The American journal of cardiology.
[49] M. Aguilar,et al. Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation , 2007, Annals of Internal Medicine.
[50] D L McGee,et al. Duration of atrial fibrillation and imminence of stroke: the Framingham study. , 1983, Stroke.
[51] A. Hofman,et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. , 2006, European heart journal.
[52] S. Iliceto,et al. Prevalence, functional impact, and mortality of atrial fibrillation in an older Italian population (from the Pro.V.A. study). , 2009, The American journal of cardiology.
[53] P. T. Onundarson,et al. Chronic atrial fibrillation--epidemiologic features and 14 year follow-up: a case control study. , 1987, European heart journal.
[54] J Raftery,et al. A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study. , 2005, Health technology assessment.
[55] S. Bansil,et al. Detection of atrial fibrillation in patients with acute stroke. , 2004, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[56] M. Mendes,et al. Prevalence of atrial fibrillation in the Portuguese population aged 40 and over: the FAMA study. , 2010, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.
[57] Colin R Simpson,et al. A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland , 2007, Heart.
[58] D. Hu,et al. An Epidemiological Study on the Prevalence of Atrial Fibrillation in the Chinese Population of Mainland China , 2008, Journal of epidemiology.
[59] K. Kimura,et al. Prevalence of atrial fibrillation in community-dwelling Japanese aged 40 years or older in Japan: analysis of 41,436 non-employee residents in Kurashiki-city. , 2008, Circulation journal : official journal of the Japanese Circulation Society.
[60] Y. Friedlander,et al. A comparison of risk factors for coronary heart disease and ischaemic stroke: the Dubbo study of Australian elderly. , 2009, Heart, lung & circulation.
[61] Z. Yuan,et al. Risk of stroke in patients with atrial flutter. , 2001, The American journal of cardiology.
[62] S. Willich,et al. The impact of atrial fibrillation on the cost of stroke: the berlin acute stroke study. , 2007, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[63] R. Sandhu,et al. The epidemiology of atrial fibrillation in adults depends on locale of diagnosis. , 2011, American heart journal.
[64] R B D'Agostino,et al. Secular trends in the prevalence of atrial fibrillation: The Framingham Study. , 1996, American heart journal.